Sign in

CIK 0001761612

  • Non-accelerated filer
  • Smaller reporting company

BICYCLE THERAPEUTICS PLC

Sign in to watch
Ticker
BCYC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+44 1223261503
Business address
BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
Former names
BICYCLE THERAPEUTICS Ltd
  1. 4 Grant or award Director acquired 24,000 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Open-market sale CHIEF PROD & SUPPLY CHAIN OFF sold 257 shares at $22.49 ($5,780)
  4. 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 3,158 shares at $23.81 ($75,192)
  5. 4 Open-market sale CHIEF TECHNOLOGY OFFICER sold 955 shares at $23.81 ($22,739)
  6. 4 Open-market sale CHIEF OPERATING OFFICER sold 955 shares at $23.81 ($22,739)
  7. 4 Open-market sale CHIEF BUSINESS OFFICER sold 955 shares at $23.81 ($22,739)
  8. 4 Open-market sale CHIEF SCIENTIFIC OFFICER sold 790 shares at $23.81 ($18,810)
  9. 4 Open-market sale CHIEF ACCOUNTING OFFICER sold 152 shares at $23.81 ($3,619)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Grant or award Director acquired 12,000 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Grant or award CHIEF DEVELOPMENT OFFICER acquired 21,660 shares (grant or award)
  15. 4 Open-market sale Chief Accounting Officer sold 604 shares at $17.50 ($10,570)
  16. 4 Grant or award Director acquired 12,000 shares (grant or award)
  17. 4 Open-market sale Chief Scientific Officer sold 2,640 shares at $17.50 ($46,200)
  18. 4 Grant or award Director acquired 6,000 shares (grant or award)
  19. 4 Grant or award Director acquired 6,000 shares (grant or award)
  20. 4 Grant or award Director acquired 6,000 shares (grant or award)

Page 6 of 16 · 304 filings